Lawrence J. Waldman - 11 Jun 2026 Form 4 Insider Report for Apyx Medical Corp (APYX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Jun 2026, 19:00:05 UTC
Prior SEC filing
26 Mar 2026
Next SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lawrence J. Waldman

Key filing fact

Lawrence J. Waldman filed Form 4 for Apyx Medical Corp (APYX) on 15 Jun 2026.

Key facts

  • This page summarizes Lawrence J. Waldman's Form 4 filing for Apyx Medical Corp (APYX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 15 Jun 2026, 19:00.

Change

  • Previous filing in this sequence was filed on 26 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001516592 Primary reporting owner

Waldman Lawrence

Relationship
Director
Address
C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER
Signature
/s/ Lawrence J. Waldman
Signature date
15 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APYX transaction Derivative

Stock Option (Option to Buy)

Award

Transaction value
Shares
+50,000
Change %
Price
$0.000000*
Shares after
50,000
Date
11 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$4.65
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .